Suzanne M Vrancken1, Boudewijn L S Borger van der Burg2, Paul J E M Vrancken2, Gert-Aldert H Kock3, Todd E Rasmussen4, Rigo Hoencamp2,5,6,7. 1. Department of Surgery, Alrijne Hospital Leiderdorp, Simon Smitweg 1, 2353GA, Leiderdorp, The Netherlands. smvrancken@alrijne.nl. 2. Department of Surgery, Alrijne Hospital Leiderdorp, Simon Smitweg 1, 2353GA, Leiderdorp, The Netherlands. 3. Department of Radiology, Alrijne Hospital, Leiderdorp, The Netherlands. 4. The Department of Surgery, The Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA. 5. Defense Healthcare Organization, Ministry of Defense, Utrecht, The Netherlands. 6. Leiden University Medical Centre, Leiden, The Netherlands. 7. Trauma Research Unit, Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Abstract
PURPOSE: Use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) as adjunct for temporary hemorrhage control in patients with exsanguinating torso hemorrhage is increasing. Characteristics of aortic occlusion balloons (AOB) are diverse and evolving as efforts are made to improve the technology. It is important to select a device that fits the requirements of the medical situation to minimize the risk of failure and complications. The aim of this study is to appraise guidance in the choice of an AOB in a specific situation. METHODS: We assessed 29 AOB for differences and outline possible advantages and disadvantages of each. Bending stiffness was measured with a three-point bending device. RESULTS: Diameter of the AOB ranged from 6 (ER-REBOA™) to 10 (Coda®-46) French. However, some need large-bore access sheaths up to 22 French (Fogarty®-45 and LeMaitre®-45) or even insertion via cut-down (Equalizer™-40). Bending stiffness varied from 0.08 N/mm (± 0.008 SD; Coda®-32) to 0.72 N/mm (± 0.024 SD; Russian prototype). Rescue Balloon™ showed kinking of the shaft at low bending pressures. The only non-compliant AOB is REBOA Balloon®. ER-REBOA™, Fogarty®, LeMaitre®, REBOA Balloon®, and Rescue Balloon™ are provided with external length marks to assist blind positioning. CONCLUSION: In resource-limited settings, a guidewire- and fluoroscopy-free, rather stiff device, such as ER-REBOA™, Fogarty®, and LeMaitre®, is warranted. Of these devices, ER-REBOA™ is the only catheter compatible with seven French sheaths and specifically designed for emergency hemorrhage control. Of the over-the-wire devices, Q50® has several features that facilitate use and reduce the risk of malplacement or vessel damage.
PURPOSE: Use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) as adjunct for temporary hemorrhage control in patients with exsanguinating torso hemorrhage is increasing. Characteristics of aortic occlusion balloons (AOB) are diverse and evolving as efforts are made to improve the technology. It is important to select a device that fits the requirements of the medical situation to minimize the risk of failure and complications. The aim of this study is to appraise guidance in the choice of an AOB in a specific situation. METHODS: We assessed 29 AOB for differences and outline possible advantages and disadvantages of each. Bending stiffness was measured with a three-point bending device. RESULTS: Diameter of the AOB ranged from 6 (ER-REBOA™) to 10 (Coda®-46) French. However, some need large-bore access sheaths up to 22 French (Fogarty®-45 and LeMaitre®-45) or even insertion via cut-down (Equalizer™-40). Bending stiffness varied from 0.08 N/mm (± 0.008 SD; Coda®-32) to 0.72 N/mm (± 0.024 SD; Russian prototype). Rescue Balloon™ showed kinking of the shaft at low bending pressures. The only non-compliant AOB is REBOA Balloon®. ER-REBOA™, Fogarty®, LeMaitre®, REBOA Balloon®, and Rescue Balloon™ are provided with external length marks to assist blind positioning. CONCLUSION: In resource-limited settings, a guidewire- and fluoroscopy-free, rather stiff device, such as ER-REBOA™, Fogarty®, and LeMaitre®, is warranted. Of these devices, ER-REBOA™ is the only catheter compatible with seven French sheaths and specifically designed for emergency hemorrhage control. Of the over-the-wire devices, Q50® has several features that facilitate use and reduce the risk of malplacement or vessel damage.
Authors: Anders J Davidson; Rachel M Russo; Viktor A Reva; Megan L Brenner; Laura J Moore; Chad Ball; Eileen Bulger; Charles J Fox; Joseph J DuBose; Ernest E Moore; Todd E Rasmussen Journal: J Trauma Acute Care Surg Date: 2018-01 Impact factor: 3.313
Authors: Joseph M White; Jeremy W Cannon; Adam Stannard; Nickolay P Markov; Jerry R Spencer; Todd E Rasmussen Journal: Surgery Date: 2011-09 Impact factor: 3.982
Authors: Nickolay P Markov; Thomas J Percival; Jonathan J Morrison; James D Ross; Daniel J Scott; Jerry R Spencer; Todd E Rasmussen Journal: Surgery Date: 2013-02-27 Impact factor: 3.982
Authors: B L S Borger van der Burg; J Van Schaik; J J W M Brouwers; C Y Wong; T E Rasmussen; J F Hamming; R Hoencamp Journal: Injury Date: 2018-12-19 Impact factor: 2.586
Authors: Megan Brenner; Eileen M Bulger; Debra G Perina; Sharon Henry; Christopher S Kang; Michael F Rotondo; Michael C Chang; Leonard J Weireter; Michael Coburn; Robert J Winchell; Ronald M Stewart Journal: Trauma Surg Acute Care Open Date: 2018-01-13
Authors: Marcelo A F Ribeiro Junior; Celia Y D Feng; Alexander T M Nguyen; Vinicius C Rodrigues; Giovana E K Bechara; Raíssa Reis de-Moura; Megan Brenner Journal: World J Emerg Surg Date: 2018-05-11 Impact factor: 5.469
Authors: Carlos A Ordoñez; Michael W Parra; Yaset Caicedo; Natalia Padilla; Fernando Rodríguez-Holguín; José Julián Serna; Alexander Salcedo; Alberto García; Claudia Orlas; Luis Fernando Pino; Ana Milena Del Valle; David Mejia; Juan Carlos Salamea-Molina; Megan Brenner; Tal Hörer Journal: Colomb Med (Cali) Date: 2020-12-30
Authors: Adam Power; Asha Parekh; Oonagh Scallan; Shane Smith; Teresa Novick; Neil Parry; Laura Moore Journal: Trauma Surg Acute Care Open Date: 2021-01-08
Authors: Suzanne M Vrancken; Boudewijn L S Borger van der Burg; Joseph J DuBose; Jacob J Glaser; Tal M Hörer; Rigo Hoencamp Journal: J Trauma Acute Care Surg Date: 2022-01-21 Impact factor: 3.697